Patents by Inventor Ilana Kolodkin-Gal

Ilana Kolodkin-Gal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230416750
    Abstract: An oligonucleotide is provided. The oligonucleotide comprising a nucleic acid sequence of at least one DNAzyme, the DNAzyme being capable of silencing at least one target gene of a bacteria to thereby render the bacteria susceptible to antibiotic treatment.
    Type: Application
    Filed: November 9, 2021
    Publication date: December 28, 2023
    Applicant: 1E Therapeutics Ltd.
    Inventors: Ido Bachelet, Almogit Horowitz, Alexander Rosenberg, Anastasia Shapiro, Ron Oshri, Ilana Kolodkin-Gal, Adva Levy-Zamir, Gat Krieger, Ella GILLIS, Shmulik ITTAH
  • Publication number: 20210144999
    Abstract: The present invention provides anti-microbial compositions comprising a hydroxycinnamic acid and related conjugates, analogues and derivatives, and methods of use thereof for enhancing production of anti-microbial agents in bacteria as well as for protecting plants from microbial infection.
    Type: Application
    Filed: July 9, 2018
    Publication date: May 20, 2021
    Applicants: YEDA RESEARCH AND DEVELOPMENT CO. LTD., THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
    Inventors: Ilana KOLODKIN-GAL, Yaara OPPENHEIMER-SHAANAN, Ariel OGRAN-NACHMAN, Michael MEIJLER, Eliane Hadas YARDENI
  • Publication number: 20210015889
    Abstract: Methods of disrupting a biofilm and/or preventing formation of a biofilm are provided. Accordingly there is provided a method of reducing or preventing formation of a biofilm and/or disrupting a biofilm comprising contacting a biofilm-producing microorganism with a carbonic anhydrase inhibitor; a urease inhibitor; a Ca2+ ATPase inhibitor; a tlp activator; and/or a myo-inositol catabolism pathway activator. Also provided are articles of manufacture and methods of treating a medical condition in which disrupting a biofilm and/or preventing formation of same is beneficial and methods of predicting or increasing sensitivity to an anti-microbial agent.
    Type: Application
    Filed: September 29, 2020
    Publication date: January 21, 2021
    Applicants: Yeda Research and Development Co. Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Ilana KOLODKIN-GAL, Alona KEREN-PAZ, Eitan KEREM, Gideon ZAMIR, Dror KOLODKIN-GAL, Malena COHEN-CYMBERKNOH
  • Publication number: 20200367493
    Abstract: The present invention relates to the identification and use of natural plant compounds for inducing, enhancing and maintaining beneficial rhizobacteria biofilm formation on a plant or plant part thereof, and conversely, inhibiting formation of biofilms and pellicle by plant pathogens. Methods of use for stimulating matrix production from the beneficial rhizobacteria and enhanced adhesion of the rhizobacteria to a plant or plant part thereof are also described. Methods of use for inhibition plant pathogen adhesion to biofilms are also described.
    Type: Application
    Filed: June 6, 2017
    Publication date: November 26, 2020
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Ilana KOLODKIN-GAL, Asaph AHARONI
  • Patent number: 9012152
    Abstract: Isolated peptides comprising no more than ten amino acids and having anti-bacterial properties are disclosed. In one embodiment the peptides have a consensus amino acid sequence X1X2X3X4X5, wherein X1 and X5 comprise polar amino acids. In another embodiment, the peptides have a consensus amino acid sequence X1X2X3X4X5, wherein X2 and X4 are asparagine (N) residues and X3 is tryptophan (W). Compositions comprising same are also disclosed and uses thereof.
    Type: Grant
    Filed: January 8, 2008
    Date of Patent: April 21, 2015
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Hanna Engelberg-Kulka, Ilana Kolodkin-Gal
  • Publication number: 20100104607
    Abstract: Isolated peptides comprising no more than ten amino acids and having anti-bacterial properties are disclosed. In one embodiment the peptides have a consensus amino acid sequence X1X2X3X4X5, wherein X1 and X5 comprise polar amino acids. In another embodiment, the peptides have a consensus amino acid sequence X1X2X3X4X5, wherein X2 and X4 are asparagine (N) residues and X3 is tryptophan (W). Compositions comprising same are also disclosed and uses thereof.
    Type: Application
    Filed: January 8, 2008
    Publication date: April 29, 2010
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Hanna Engelberg-Kulka, Ilana Kolodkin-Gal